Theravance Biopharma TBPH Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's short-term investments?
- Theravance Biopharma (TBPH) reported short-term investments of $106.57M in Q1 2026.
- How has Theravance Biopharma's short-term investments changed year-over-year?
- Theravance Biopharma's short-term investments increased by 426.5% year-over-year, from $20.24M to $106.57M.
- What is the long-term trend for Theravance Biopharma's short-term investments?
- Over 5 years (2020 to 2025), Theravance Biopharma's short-term investments has grown at a -6.9% compound annual growth rate (CAGR), from $211.47M to $147.55M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.